Goodness Growth Holdings, Inc. GDNSF
We take great care to ensure that the data presented and summarized in this overview for Goodness Growth Holdings, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding GDNSF
View allLatest Institutional Activity in GDNSF
Top Purchases
Top Sells
About GDNSF
Goodness Growth Holdings, Inc. operates as a physician-led cannabis company in the United States. The company cultivates cannabis in environmentally friendly greenhouses; manufactures pharmaceutical-grade cannabis extracts; and sells its products through its network of Green Goods and other Goodness Growth branded retail dispensaries, as well as third-party dispensaries. As of March 11, 2022, it operated 18 dispensaries, which included 2 in Maryland, 8 in Minnesota, 4 in New Mexico, and 4 in New York; and offered wholesale cannabis products through third-party companies in Arizona, Maryland, Minnesota, and New York. The company was formerly known as Vireo Health International Inc. and changed its name to Goodness Growth Holdings, Inc. in June 2021. Goodness Growth Holdings, Inc. is headquartered in Minneapolis, Minnesota.
Insider Transactions at GDNSF
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 29
2025
|
Tyson Macdonald Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,390,395
-15.92%
|
$0
$0.6 P/Share
|
|
Dec 29
2025
|
John Mazarakis Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,303,999
-15.97%
|
$0
$0.6 P/Share
|
|
Dec 29
2025
|
Sean Michael Apfelbaum GC and Corporate Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
62,145
-31.07%
|
$0
$0.64 P/Share
|
|
Dec 29
2025
|
Kyle Eugene Kingsley Co-Executive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct |
1,701,680
-5.97%
|
$0
$0.64 P/Share
|
|
Dec 29
2025
|
Amber Holly Shimpa President |
SELL
Payment of exercise price or tax liability
|
Direct |
126,666
-10.16%
|
$0
$0.6 P/Share
|
|
Dec 17
2025
|
Tyson Macdonald Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,038,707
+21.45%
|
-
|
|
Dec 17
2025
|
John Mazarakis Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,900,000
+26.36%
|
-
|
|
Nov 13
2025
|
Tyson Macdonald Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,018,868
+20.89%
|
-
|
|
Nov 13
2025
|
John Mazarakis Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,037,736
+28.01%
|
-
|
|
Sep 30
2025
|
Sean Michael Apfelbaum GC and Corporate Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
200,000
+50.0%
|
-
|
|
Jun 13
2025
|
Amber Holly Shimpa President |
BUY
Conversion of derivative security
|
Direct |
852,100
+40.6%
|
-
|
|
Jun 13
2025
|
Chicago Atlantic Opportunity Portfolio, LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
5,000
+0.02%
|
$0
$0.41 P/Share
|
|
Jun 12
2025
|
Chicago Atlantic Opportunity Portfolio, LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
70,000
+0.21%
|
$0
$0.42 P/Share
|
|
Jun 11
2025
|
Chicago Atlantic Opportunity Portfolio, LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
113,900
+0.34%
|
$0
$0.4 P/Share
|
|
Jun 10
2025
|
Chicago Atlantic Opportunity Portfolio, LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
55,700
+0.17%
|
$0
$0.4 P/Share
|
|
Jun 09
2025
|
Chicago Atlantic Opportunity Portfolio, LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
36,600
+0.11%
|
$0
$0.41 P/Share
|
|
Jun 06
2025
|
Chicago Atlantic Opportunity Portfolio, LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
49,900
+0.15%
|
$0
$0.41 P/Share
|
|
Jun 05
2025
|
Chicago Atlantic Opportunity Portfolio, LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
6,000
+0.02%
|
$0
$0.4 P/Share
|
|
Jun 04
2025
|
Chicago Atlantic Opportunity Portfolio, LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
20,000
+0.06%
|
$0
$0.41 P/Share
|
|
Jun 03
2025
|
Chicago Atlantic Opportunity Portfolio, LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
165,000
+0.5%
|
$0
$0.4 P/Share
|
Last 12 Months Summary
| Grant, award, or other acquisition | 16M shares |
|---|---|
| Conversion of derivative security | 852K shares |
| Open market or private purchase | 1.2M shares |
| Exercise of conversion of derivative security | 200K shares |
| Payment of exercise price or tax liability | 8.58M shares |
|---|